amphetamine has been researched along with clozapine in 96 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (23.96) | 18.7374 |
1990's | 19 (19.79) | 18.2507 |
2000's | 32 (33.33) | 29.6817 |
2010's | 19 (19.79) | 24.3611 |
2020's | 3 (3.13) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lassen, JB | 1 |
Marsden, CD; Pycock, CJ; Tarsy, D | 1 |
Altier, H; Monti, JM; Souto, M | 1 |
Arushanian, EB; Tolpyshev, BA | 1 |
Korf, J; Westerink, BH | 1 |
Fielding, S; Lal, H; Marky, M | 1 |
Fog, R | 1 |
Belknap, JK; de Paulis, T; Janowsky, A; Kinzie, JM; Neve, KA; Taylor, B | 1 |
Ghidoni, R; Haselhorst, U; Schenk, H | 1 |
Mott, J; Sherman, AD | 1 |
Johnson, KM; Snell, LD | 1 |
el Mestikawy, S; Glowinski, J; Hamon, M | 1 |
Ramirez, OA; Wang, RY | 1 |
Krähling, H; Ruhland, M; Schmidt, WJ | 1 |
Compton, DR; Johnson, KM | 1 |
Arbilla, S; Baud, P; Langer, SZ | 1 |
Hoffmann, WE; Piercey, MF; Travis, M; Vogelsang, GD | 1 |
Dews, PB; Lehr, E; Morse, WH | 1 |
Biazzi, A; Fregnan, GB | 1 |
Likhosherstov, AM; Rayevskii, KS; Röhnert, H; Rostock, A; Rüger, C; Skoldinov, AP; Stavrovskaja, AW | 1 |
Nobrega, JN; Wiener, NI | 1 |
De Feo, G; Lisciani, R; Pavan, L; Samarelli, M; Valeri, P | 1 |
Brugge, K; McPherson, FA; Peirson, EE; Rebec, GV | 1 |
Arushanian, EB; Smirnova, LE; Tolpyshev, BA | 1 |
Donovan, H; Hoffman, DC | 1 |
Bervoets, K; Maurel-Remy, S; Millan, MJ | 1 |
Kenyon, P; Moore, S | 1 |
Clemens, AJ; Pierce, RC; Rebec, GV; Shapiro, LA | 1 |
Goldstein, JM; Litwin, LC; Malick, JB; Sutton, EB | 1 |
Papanikolaou, A; Salamone, JD; Sokolowski, JD; Steinpreis, RE | 1 |
Ewing, FE; Furman, JS; Howard, HR; Jackson, E; Johnson, C; Lowe, JA; Maloney, PR; Morrone, J; Newman, ME; Robinson, GL; Schmidt, AW; Seeger, TF; Seymour, PA; Zorn, SH | 1 |
Rebec, GV; Wang, Z | 1 |
Fox, DA; Shulman, LM | 1 |
Cooper, BR; Cox, RF; Durcan, MJ; Gengo, PJ; Jones-Humble, SA; Lyerly, D; Morgan, PF; Norton, RM; Russell, AV; Tang, FL; Wang, CM; Watson, MJ | 1 |
Rasmussen, K; Stockton, ME | 1 |
Arnt, J | 1 |
Bardgett, ME; Csernansky, JG; Jackson, JL; Taylor, BM | 1 |
Feldpaush, DL; Meng, ZH; Merchant, KM | 1 |
Adler, CM; Breier, A; Elman, I; Malhotra, AK; Pickar, D; Su, TP; Weisenfeld, NI | 1 |
Dadmarz, M; Ufer, M; Vogel, WH | 1 |
Gerlach, J; Peacock, L | 1 |
Audinot, V; Brocco, M; Dekeyne, A; Despaux, N; Maiofiss, L; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Queriaux, S; Rivet, JM | 1 |
Dai, J; Guan, HJ; Zhu, XZ | 1 |
Cilia, J; Hagan, JJ; Piper, DC; Upton, N | 1 |
Bruhwyler, J; Cools, AR; Ellenbroek, BA; Liégeois, JF | 1 |
Feldon, J; Murphy, CA; Russig, H | 1 |
Bubser, M; Deutch, AY; Fadel, J | 1 |
Brodbeck, R; He, X; Hoffman, D; Kieltyka, A; Primus, R; Thurkauf, A; Wasley, JW; Zhao, H | 1 |
Bucan, M; Fetsko, LA; Hranilovic, D; Wang, Y; Xu, R | 1 |
Herman, ZS; Obuchowicz, E | 1 |
Rimmerman, N; Weiner, I; Zuckerman, L | 1 |
Nachman, R; Rehavi, M; Weiner, I; Zuckerman, L | 1 |
Feldon, J; Kovacevic, A; Murphy, CA; Russig, H | 1 |
Markou, A; Semenova, S | 1 |
Joy, B; McMahon, RP; Shepard, PD | 1 |
Carlson, PJ; Merlock, MC; Suppes, T | 1 |
Fletcher, PJ; Kapur, S; Tenn, CC | 1 |
Deitemeyer, N; Dobner, PR; Egnatashvili, V; Kinkead, B; Murray, T; Nemeroff, CB | 1 |
Alimohamad, H; Mouyal, J; Rajakumar, N; Rushlow, WJ; Sutton, L | 1 |
Kruse, CG; McCreary, AC; Olijslagers, JE; Perlstein, B; Siarey, R; Wadman, WJ; Werkman, TR | 1 |
Gizerian, SS; Grobin, AC; Lieberman, JA; Moy, SS | 1 |
Ko, F; Seeman, P; Tallerico, T | 1 |
Bortolato, M; Carta, M; Collu, M; Fadda, F; Frau, R; Mereu, G; Orrù, M; Stancampiano, R | 1 |
Crabbe, JC; Philibin, SD; Porter, JH; Vunck, SA; Walentiny, DM | 1 |
Barlow, KB; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE | 1 |
Gozes, I; Malkoff, A; Rehavi, M; Weizman, A | 1 |
Feldon, J; Meyer, U; Schwarz, MJ; Spoerri, E; Yee, BK | 1 |
Hu, G; Li, M; Sun, T | 1 |
Feldon, J; Singer, P; Yee, BK | 1 |
Arancio, O; Balsam, P; Chuhma, N; Conjard-Duplany, A; Fairhurst, S; Gaisler-Salomon, I; Galloway, MP; Ghoddoussi, F; Hen, R; Lee, S; Lewandowski, N; Masson, J; Miller, GM; Moore, HM; Rayport, S; Small, SA; Wang, Y; Zhang, H | 1 |
Alexander, KS; Brooks, JM; Bruno, JP; Sarter, M | 1 |
Assaf, Y; Piontkewitz, Y; Weiner, I | 1 |
Avenet, P; Bergis, O; Boulay, D; Griebel, G | 1 |
Boules, M; Briody, S; Fauq, I; Oliveros, A; Richelson, E | 1 |
Lipina, T; Roder, J | 1 |
Arad, M; Weiner, I | 1 |
Basta-Kaim, A; Budziszewska, B; Fijał, K; Kubera, M; Lasoń, W; Leśkiewicz, M; Regulska, M; Wędzony, K | 1 |
Dong, Y; Eskenazi, D; Ferguson, SM; Ishikawa, M; Neumaier, JF; Phillips, PE; Roth, BL; Wanat, MJ | 1 |
Figueredo, VM | 1 |
Abílio, VC; Calzavara, MB; Levin, R; Medrano, WA; Niigaki, ST; Santos, CM | 1 |
Li, M; Mead, A; Sun, T | 1 |
Calakos, N; Caron, MG; Daigle, TL; Farrell, MS; Guettier, JM; Huang, XP; Hufeisen, SJ; Lee, HM; Moy, SS; Nonneman, RJ; Pei, Y; Roth, BL; Sciaky, N; Simmons, A; Urban, DJ; Wan, Y; Wess, J; Yadav, PN | 1 |
Casanova, JP; Escobar, F; Fuentealba, JA; Gatica, RI; Herrera, AS | 1 |
Hacksell, U; Hubbard, D; McFarland, K | 1 |
Baune, BT; Greenberg, Z; Jaehne, EJ; Kabbara, S; Lopez, A; McCarthy, P; McClure, B; Parish, C; Ramshaw, H; Saleh, E; Schwarz, Q; van den Buuse, M; Wang, TY; Wiszniak, S; Woodcock, J; Xu, X | 1 |
Adan, RA; Beloate, LN; Coolen, LM; Omrani, A; Webb, IC | 1 |
Ahnaou, A; Drinkenburg, WHIM; Huysmans, H; Van de Casteele, T | 1 |
Crippa, JAS; Del Bel, E; Guimarães, FS; Joca, SRL; Pedrazzi, JFC; Sales, AJ | 1 |
Bousman, CA; Danilewitz, M; Frankow, L; Honer, WG; Mahmood, H; Mathew, N; Poonia, S; Rafizadeh, R; Schütz, CG | 1 |
Chohan, MO; Fein, H; Mirro, S; O'Reilly, KC; Veenstra-VanderWeele, J | 1 |
2 review(s) available for amphetamine and clozapine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart.
Topics: Amphetamine; Anabolic Agents; Anthracyclines; Antineoplastic Agents; Cardiomyopathies; Chloroquine; Clozapine; Cocaine; Doxorubicin; Ephedra; Ethanol; Heart; Humans; Methylphenidate; Nonprescription Drugs; Prescription Drugs; Testosterone | 2011 |
2 trial(s) available for amphetamine and clozapine
Article | Year |
---|---|
Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders.
Topics: Adult; Amphetamine; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neostriatum; Psychotic Disorders; Raclopride; Risperidone; Salicylamides; Tomography, Emission-Computed | 1999 |
Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
Topics: Adult; Aged; Amphetamine; Antipsychotic Agents; Bipolar Disorder; Central Nervous System Stimulants; Clozapine; Consciousness Disorders; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Middle Aged; Retrospective Studies | 2004 |
92 other study(ies) available for amphetamine and clozapine
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats.
Topics: Amphetamine; Animals; Butyrophenones; Clozapine; Diazepam; Diphenhydramine; Grooming; Haloperidol; Male; Norepinephrine; Phenothiazines; Rats; Tyramine | 1977 |
Inhibition of turning behaviour by clozapine in mice with unilateral destruction of dopaminergic nerve terminals.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Clozapine; Corpus Striatum; Dibenzazepines; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Male; Mice; Models, Biological; Motor Activity; Time Factors | 1975 |
Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons.
Topics: Amphetamine; Animals; Brain; Clozapine; Dibenzazepines; Dopamine; Electric Stimulation; Locus Coeruleus; Male; Neurons; Norepinephrine; Rats; Substantia Nigra | 1979 |
[Effect of clozapine on the behavioral and electrographic indices of the arrest function of the caudate nucleus in cats].
Topics: Amphetamine; Animals; Behavior, Animal; Cats; Caudate Nucleus; Clozapine; Dibenzazepines; Dose-Response Relationship, Drug; Electroencephalography; Female; Humans; Inhibition, Psychological; Male; Stereotyped Behavior | 1978 |
Acidic dopamine metabolites in cortical areas of the rat brain: localization and effects of drug.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Apomorphine; Cerebral Cortex; Clozapine; Corpus Striatum; Haloperidol; Homovanillic Acid; Male; Morphine; Olfactory Bulb; Oxotremorine; Phenylacetates; Probenecid; Rats; Sulpiride; Thioridazine | 1976 |
Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
Topics: Amphetamine; Animals; Behavior; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Levodopa; Male; Mice; Pimozide; Promethazine; Psychotropic Drugs; Stereotyped Behavior; Thioridazine; Tranquilizing Agents | 1976 |
Neuroleptic action of clozapine injected into various brain areas in rats.
Topics: Amphetamine; Animals; Brain; Catalepsy; Cerebral Cortex; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Hippocampus; Humans; Injections; Male; Rats; Stereotyped Behavior; Thalamus; Tranquilizing Agents | 1975 |
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Topics: Amphetamine; Animals; Autoradiography; Benzamides; Brain; Clozapine; Haloperidol; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone | 1992 |
Changes of brain gangliosides in the frontal cortex of rats chronically treated with amphetamine, clozapine, haloperidol and ethanol.
Topics: Amphetamine; Animals; Cerebral Cortex; Chromatography, Thin Layer; Clozapine; Ethanol; Gangliosides; Haloperidol; Male; Rats; Rats, Inbred Strains | 1991 |
Amphetamine stimulation of glutaminase is blocked by neuroleptics.
Topics: Amphetamine; Animals; Antipsychotic Agents; Brain; Butaclamol; Chlorpromazine; Clozapine; Enzyme Activation; Glutaminase; Haloperidol; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Stereoisomerism | 1985 |
Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
Topics: Acetylcholine; Amphetamine; Animals; Apomorphine; Aspartic Acid; Benzomorphans; Chlorpromazine; Clozapine; Corpus Striatum; Cyclazocine; Dioxolanes; Dopamine; Haloperidol; Ketamine; Male; Mathematics; Motor Activity; N-Methylaspartate; Phencyclidine; Posture; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
Topics: Amphetamine; Animals; Bucladesine; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine; Enzyme Activation; Haloperidol; Hippocampus; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Sulpiride; Synapses; Synaptosomes; Tyrosine 3-Monooxygenase; Veratridine | 1986 |
Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine.
Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Clozapine; Dibenzazepines; Electric Stimulation; Haloperidol; Locus Coeruleus; Male; Norepinephrine; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Behavior, Animal; Benzodiazepines; Clozapine; Dibenzazepines; Haloperidol; Male; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Stereotyped Behavior; Valine | 1987 |
Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Topics: Acetylcholine; Amphetamine; Animals; Clozapine; Corpus Striatum; Dibenzazepines; Dopamine; Electric Stimulation; Haloperidol; In Vitro Techniques; Male; Nalidixic Acid; Naphthyridines; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Tetrahydronaphthalenes | 1989 |
Inhibition of the electrically evoked release of [3H]acetylcholine in rat striatal slices: an experimental model for drugs that enhance dopaminergic neurotransmission.
Topics: Acetylcholine; Amphetamine; Animals; Chlorpromazine; Clozapine; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Haloperidol; Male; Nomifensine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Synaptic Transmission | 1985 |
Electrophysiological evaluation of a partial agonist of dopamine receptors.
Topics: Amphetamine; Animals; Apomorphine; Clozapine; Dose-Response Relationship, Drug; Electric Stimulation; Ergolines; Haloperidol; Lisuride; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1987 |
Effects of drugs on schedule-controlled running of mice in a circular runway.
Topics: Amphetamine; Animals; Chlordiazepoxide; Chlorpromazine; Clozapine; Female; Food Deprivation; Imipramine; Mice; Morphine; Motor Activity; Pentobarbital; Reinforcement Schedule | 1985 |
Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Clozapine; Dopamine; Dopamine Antagonists; Drug Tolerance; Female; Haloperidol; Hypnotics and Sedatives; Male; Mice; Motor Activity; Oxazoles; Piperazines; Receptors, Dopamine; Time Factors | 1980 |
[Synthesis and neurologic action of new 11-substituted 5H-dibenzo[b,e][1,4]diazepines].
Topics: Aggression; Amphetamine; Analgesics; Animals; Brain Chemistry; Chemical Phenomena; Chemistry; Clozapine; Dibenzazepines; Hexobarbital; Homovanillic Acid; Humans; Lethal Dose 50; Mice; Motor Activity; Physostigmine; Psychotropic Drugs; Rats; Sleep | 1984 |
Effects of catecholamine agonist and antagonist drugs on acute stomach ulceration induced by medial hypothalamic lesions in rats.
Topics: Amphetamine; Animals; Catecholamines; Chlorpromazine; Clozapine; Desipramine; Haloperidol; Hypothalamus, Middle; Isoproterenol; Male; Pargyline; Phentolamine; Propranolol; Rats; Rats, Inbred Strains; Stomach Ulcer | 1983 |
Possible dopaminergic involvement in biting compulsion induced by large doses of clonidine.
Topics: Aggression; Amphetamine; Animals; Clonidine; Clozapine; Dopamine; Drug Interactions; Female; Haloperidol; Humans; Male; Mice; Phenoxybenzamine; Scopolamine | 1983 |
Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol.
Topics: Amphetamine; Animals; Behavior, Animal; Clozapine; Dibenzazepines; Drug Tolerance; Haloperidol; Humans; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1982 |
[Possible discrepancy between behavioral adequacy and motor automatisms in cats with phenamine-induced stereotypy].
Topics: Amphetamine; Animals; Cats; Clozapine; Dibenzazepines; Female; Haloperidol; Humans; Male; Metoclopramide; Stereotyped Behavior | 1981 |
Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability.
Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Clozapine; Disease Models, Animal; Extrapyramidal Tracts; Locomotion; Male; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Excitatory Amino Acid Antagonists; Fluorobenzenes; Male; Motor Activity; Phencyclidine; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 1995 |
Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion.
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Haloperidol; Male; Motor Activity; Rats; Rats, Wistar; Stereotyped Behavior; Sulpiride | 1994 |
Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Ascorbic Acid; Clozapine; Extracellular Space; Haloperidol; Male; Microelectrodes; Motor Activity; Neostriatum; Nucleus Accumbens; Rats; Rats, Sprague-Dawley | 1994 |
Seroquel: electrophysiological profile of a potential atypical antipsychotic.
Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Brain; Clozapine; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; Male; Microelectrodes; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1993 |
The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat.
Topics: Aggression; Amphetamine; Animals; Clozapine; Haloperidol; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Social Behavior | 1994 |
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Brain; Catalepsy; Clozapine; Dopamine; Drug Design; Humans; Molecular Structure; Phosphatidylinositols; Piperazines; Prazosin; Rats; Receptors, Adrenergic; Receptors, Dopamine; Serotonin Antagonists; Thiazoles | 1996 |
Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine.
Topics: Amphetamine; Amygdala; Animals; Behavior, Animal; Clozapine; Haloperidol; Locomotion; Male; Rats; Rats, Sprague-Dawley | 1996 |
Dopamine inhibits mammalian photoreceptor Na+,K+-ATPase activity via a selective effect on the alpha3 isozyme.
Topics: Aminobutyrates; Amphetamine; Animals; Benzazepines; Clozapine; Darkness; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Agonists; Female; In Vitro Techniques; Isoenzymes; Kynurenic Acid; Light; Ouabain; Oxygen Consumption; Photoreceptor Cells; Rats; Retina; Retinal Rod Photoreceptor Cells; Rod Cell Outer Segment; Sodium-Potassium-Exchanging ATPase | 1996 |
Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Biogenic Amines; Brain; Clozapine; Male; Neurons; Piperazines; Radioligand Assay; Rats; Thiazoles | 1996 |
Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Agents; Electrophysiology; Male; Mesencephalon; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley | 1996 |
Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Clozapine; Discrimination Learning; Dose-Response Relationship, Drug; Haloperidol; Male; Rats; Rats, Wistar; Reward | 1996 |
The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Motor Activity; Rats; Rats, Sprague-Dawley | 1998 |
Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Gene Expression Regulation; Genes, fos; Haloperidol; In Situ Hybridization; Injections, Subcutaneous; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Peptide Fragments; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1998 |
Voluntary consumption of amphetamine, cocaine, ethanol and morphine by rats as influenced by a preceding period of forced drug intake and clozapine.
Topics: Administration, Oral; Amphetamine; Animals; Central Nervous System Depressants; Clozapine; Cocaine; Dopamine Agents; Ethanol; Male; Morphine; Narcotics; Rats; Rats, Sprague-Dawley; Self Administration; Substance-Related Disorders | 1999 |
New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects.
Topics: Amphetamine; Animals; Antipsychotic Agents; Cebus; Clozapine; Dextroamphetamine; Disease Models, Animal; Dopamine Agents; Dystonia; Female; Male; Motor Activity; Movement Disorders | 1999 |
S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multipara
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Antagonists; Aggression; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Clozapine; Cocaine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Extrapyramidal Tracts; Haloperidol; Imidazoles; Isoxazoles; Male; Mice; Pain Measurement; Protein Binding; Rats; Rats, Wistar; Receptors, Histamine; Receptors, Muscarinic | 2000 |
Atypical antipsychotic effects of quetiapine fumarate in animal models.
Topics: Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Disease Models, Animal; Female; Haloperidol; Immobilization; Male; Mice; Phencyclidine; Rats; Rats, Wistar; Schizophrenia; Schizophrenia, Paranoid | 2000 |
Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Callithrix; Central Nervous System Stimulants; Clozapine; Conditioning, Operant; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Eating; Female; Injections, Intramuscular; Male; Reinforcement Schedule | 2001 |
Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepinones; Central Nervous System Stimulants; Clozapine; Disease Models, Animal; Drug Evaluation, Preclinical; Haloperidol; Locomotion; Male; Pyridines; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia | 2001 |
Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Central Nervous System Stimulants; Clozapine; Haloperidol; Inhibition, Psychological; Male; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2002 |
Differential activation of orexin neurons by antipsychotic drugs associated with weight gain.
Topics: Amphetamine; Animals; Antipsychotic Agents; Body Weight; Carrier Proteins; Cell Count; Central Nervous System Stimulants; Clozapine; Dopamine Antagonists; Fornix, Brain; Haloperidol; Hypothalamic Area, Lateral; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; Neurons; Neuropeptides; Orexins; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Weight Gain | 2002 |
Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.
Topics: Amphetamine; Animals; Antipsychotic Agents; Binding, Competitive; Catalepsy; Central Nervous System Stimulants; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Half-Life; Haloperidol; Humans; In Vitro Techniques; Indicators and Reagents; Indoles; Motor Activity; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D4; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship | 2002 |
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine Agonists; Dose-Response Relationship, Drug; Hallucinogens; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Parkinsonian Disorders; Protein Isoforms; Raclopride; Receptors, Dopamine D2 | 2002 |
Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Hallucinogens; Haloperidol; Immunohistochemistry; Male; Motor Activity; Neostriatum; Neuropeptide Y; Nucleus Accumbens; Phencyclidine; Rats; Rats, Wistar; Stereotyped Behavior | 2003 |
Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
Topics: Aging; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Conditioning, Classical; Disease Models, Animal; Drinking Behavior; Fluorobenzenes; Male; Models, Neurological; Movement; Neural Inhibition; Piperidines; Rats; Rats, Wistar; Schizophrenia; Time Factors | 2003 |
Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Clozapine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Female; GABA Antagonists; Haloperidol; Hippocampus; In Vitro Techniques; Inhibition, Psychological; Interferon Inducers; Male; Motor Activity; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia | 2003 |
Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.
Topics: Adrenergic Agents; Amphetamine; Animals; Antipsychotic Agents; Clozapine; Haloperidol; Male; Rats; Rats, Wistar; Reaction Time; Taste | 2003 |
Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine.
Topics: Affective Symptoms; Amphetamine; Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Reward; Substance Withdrawal Syndrome | 2003 |
Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Male; Rats; Rats, Sprague-Dawley | 2004 |
A putative animal model of the "prodromal" state of schizophrenia.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Clozapine; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Haloperidol; Inhibition, Psychological; Male; Motor Activity; Neural Inhibition; Random Allocation; Rats; Rats, Sprague-Dawley; Reaction Time; Reflex, Startle; Schizophrenia; Substance Withdrawal Syndrome; Time Factors | 2005 |
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Clozapine; Dibenzothiazepines; Female; Haloperidol; Male; Mice; Mice, Inbred C57BL; Neurotensin; Olanzapine; Quetiapine Fumarate; Reflex; Reflex, Startle | 2005 |
The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
Topics: Adaptor Proteins, Signal Transducing; Amphetamine; Animals; Antipsychotic Agents; Benzazepines; beta Catenin; Blotting, Western; Central Nervous System Stimulants; Clozapine; Cytoskeletal Proteins; Dishevelled Proteins; Dopamine Agonists; Female; Glycogen Synthase Kinase 3; Haloperidol; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Male; Mesencephalon; Phosphoproteins; Quinpirole; Rats; Rats, Sprague-Dawley; Risperidone; Signal Transduction; Trans-Activators; Wnt Proteins; Wnt1 Protein | 2005 |
The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; In Vitro Techniques; Male; Mesencephalon; Neural Inhibition; Neurons; Olanzapine; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists; Sulpiride | 2005 |
Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activity.
Topics: Amphetamine; Animals; Animals, Newborn; Behavior, Animal; Clozapine; Female; GABA Antagonists; Male; Motor Activity; Pregnanolone; Rats; Rats, Sprague-Dawley; Reflex, Startle | 2006 |
Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Brain; Brain Chemistry; Chromosome Mapping; Clozapine; Dopamine Agents; Down-Regulation; Gene Expression Regulation; Haloperidol; Male; Molecular Sequence Data; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia; Up-Regulation | 2006 |
Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats.
Topics: Acoustic Stimulation; Amino Acids; Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Data Interpretation, Statistical; Diet; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Eating; Flour; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Reflex, Startle; Tryptophan; Zea mays | 2008 |
A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Discrimination Learning; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Olanzapine; Risperidone | 2008 |
Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
Topics: Amisulpride; Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Blood-Brain Barrier; Brain; Clozapine; Conditioning, Psychological; Haloperidol; Male; Models, Animal; Motor Activity; Phencyclidine; Prefrontal Cortex; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Risperidone; Sulpiride | 2008 |
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; DNA Primers; Haloperidol; Male; Muscarinic Antagonists; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Schizophrenic Psychology | 2008 |
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.
Topics: Age Factors; Amphetamine; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain; Central Nervous System Stimulants; Clozapine; Disease Models, Animal; Female; Haloperidol; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Polynucleotides; Pregnancy; Prenatal Exposure Delayed Effects; Schizophrenia; Schizophrenic Psychology; Sensory Gating | 2010 |
Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Clozapine; Disease Models, Animal; Haloperidol; Hyperkinesis; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Time Factors | 2009 |
Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Phencyclidine; Phenotype; Reflex, Startle; Schizophrenia; Species Specificity | 2009 |
Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Exploratory Behavior; Freezing Reaction, Cataleptic; Glutamic Acid; Glutaminase; Hippocampus; Image Processing, Computer-Assisted; Inhibition, Psychological; Ketamine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Motor Activity; Oxygen; Protons; Reflex, Startle; Synaptic Transmission | 2009 |
Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.
Topics: Acetylcholine; Aging; Amphetamine; Animals; Animals, Newborn; Clozapine; Disease Models, Animal; Hippocampus; Ibotenic Acid; Male; Microinjections; N-Methylaspartate; Neural Pathways; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Schizophrenia; Time Factors | 2009 |
Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.
Topics: Abnormalities, Drug-Induced; Age Factors; Amphetamine; Animals; Antipsychotic Agents; Attention; Brain Diseases; Cerebral Ventricles; Clozapine; Disease Models, Animal; Hippocampus; Inhibition, Psychological; Male; Motor Activity; Poly I-C; Rats; Rats, Wistar; Schizophrenia | 2009 |
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Plasma Membrane Transport Proteins; Glycine Plasma Membrane Transport Proteins; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Piperazines; Quinolones; Receptors, N-Methyl-D-Aspartate | 2010 |
Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Clozapine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Haloperidol; Neurotensin; Peptide Fragments; Rats; Sensory Gating | 2010 |
A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.
Topics: Amphetamine; Animals; Bupropion; Clozapine; Conditioning, Psychological; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Interactions; Haloperidol; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Neural Inhibition; Phosphodiesterase 4 Inhibitors; Piperazines; Rolipram; Schizophrenic Psychology | 2010 |
Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogens; Female; Haloperidol; Inhibition, Psychological; Ovariectomy; Psychotic Disorders; Rats; Rats, Wistar; Statistics, Nonparametric; Water Deprivation | 2010 |
Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: effects of antipsychotic drugs.
Topics: Amphetamine; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Corticosterone; Female; Frontal Lobe; Hippocampus; Hypothalamo-Hypophyseal System; Lipopolysaccharides; Male; Maternal Exposure; Maternal-Fetal Exchange; Motor Activity; Pituitary-Adrenal System; Pregnancy; Rats; Rats, Wistar; Receptors, Glucocorticoid; Reflex, Startle; Schizophrenia; Tacrolimus Binding Proteins | 2011 |
Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization.
Topics: Amphetamine; Animals; Cell Line, Transformed; Clozapine; Corpus Striatum; Dopamine; Genetic Vectors; Herpes Simplex; Humans; Male; Membrane Potentials; Motor Activity; Neural Inhibition; Neural Pathways; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M4; Reward; Ventral Tegmental Area | 2011 |
Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Clozapine; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Metoclopramide; Rats; Rats, Inbred SHR; Rats, Wistar; Reflex, Startle; Schizophrenia; Sensory Gating | 2011 |
Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Avoidance Learning; Benzodiazepines; Clozapine; Conditioning, Classical; Dose-Response Relationship, Drug; Inhibition, Psychological; Male; Olanzapine; Phencyclidine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors | 2012 |
A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Animals, Newborn; Clozapine; Cocaine; Corpus Striatum; Cyclic AMP; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Green Fluorescent Proteins; GTP-Binding Protein alpha Subunits, Gs; Locomotion; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Phosphorylation; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Receptors, Muscarinic; Red Fluorescent Protein | 2013 |
Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Drug Administration Schedule; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2013 |
Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.
Topics: Amphetamine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine; Dose-Response Relationship, Drug; Male; Parkinsonian Disorders; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Urea | 2013 |
Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.
Topics: 14-3-3 Proteins; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Mice; Mice, Knockout; Motor Activity; Neostriatum; Schizophrenia; Signal Transduction; Synaptic Transmission | 2013 |
Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Clozapine; Conditioning, Operant; Designer Drugs; Dopaminergic Neurons; Female; Gene Expression Regulation; Luminescent Proteins; Male; Neuronal Plasticity; Proto-Oncogene Proteins c-fos; Rats; Receptors, G-Protein-Coupled; Red Fluorescent Protein; Reward; Sexual Behavior, Animal; Transduction, Genetic; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2016 |
Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Brain Waves; Central Nervous System Stimulants; Cerebral Cortex; Clozapine; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; Male; Nerve Net; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone | 2017 |
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Cannabidiol; Clozapine; Dizocilpine Maleate; DNA Methylation; Epigenesis, Genetic; Hallucinogens; Male; Mice; Neuroprotective Agents; Prefrontal Cortex; Prepulse Inhibition; Reflex, Startle; Schizophrenia; Sensory Gating; Time Factors; Ventral Striatum | 2021 |
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
Topics: Amphetamine; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Female; Humans; Male; Methamphetamine; Recurrence; Retrospective Studies; Schizophrenia; Substance-Related Disorders | 2023 |
Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors.
Topics: Amphetamine; Animals; Clozapine; Dopaminergic Neurons; Mice | 2023 |